While reporting financial results for the fourth quarter on Thursday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) initiated its adjusted earnings and revenue growth outlook for the full-year 2024, above analysts' estimates.
StockNews.com lowered shares of Biglari (NYSE:BH – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday. Separately, TheStreet cut Biglari from a b- rating to a c rating in a research note on Friday, November 3rd. View Our Latest Stock Analysis on Biglari Biglari Stock Performance […]